Committee advances 340B reporting and fee framework amid debate over fees and rural impact The committee reported out Engrossed Second Substitute Senate Bill 59‑81 after adopting a striking amendment establishing HCA filing fees and a 340B reporting account; multiple amendments to remove fees, require 90% of revenues for patient care, or limit contract pharmacies to rural areas failed amid debate over federal preemption, transparency and litigation risk.

The Washington Health Care committee just approved a bill that could reshape the 340B drug pricing program, but fierce debate over fees and patient care funding continues to simmer.

Click to read more!

#WA #DrugPricingTransparency #CitizenPortal #RuralHealthAccess #HealthCareReform

Votes at a glance: committee advances multiple health bills in executive session In executive session the committee adopted substitutes/amendments and advanced SB 5916, SB 5981, SB 5985, SB 6019, SB 6161 and SB 6183 with due‑pass recommendations or referrals to Rules/Ways & Means; transcripts record verbal ayes and some nays but do not provide full numeric tallies.

The Senate Health and Long Term Care Committee is making waves by advancing multiple crucial health bills aimed at improving pain management, drug pricing transparency, and resources for endometriosis and dementia care.

Click to read more!

#WA #DrugPricingTransparency #PublicHealthResources

California lawmakers address rising specialty drug costs and affordability crisis Legislators propose bills to increase transparency and control skyrocketing specialty drug prices in California.

California lawmakers are sounding the alarm as skyrocketing specialty drug prices force patients to choose between lifesaving medications and basic needs like food and housing.

Click to read more!

#SanFranciscoCounty #CA #PatientAffordability #SanFranciscoCounty #DrugPricingTransparency

Massachusetts Secretary discusses drug costs and transparency challenges with lawmakers Secretary addresses pharmaceutical transparency issues and budget concerns for Massachusetts healthcare.

Massachusetts lawmakers are tackling the soaring costs of pharmaceuticals and the hidden role of Pharmacy Benefit Managers, pushing for urgent reforms that could reshape healthcare access for all.

Learn more here!

#MA #CitizenPortal #HealthcareAccessibility #DrugPricingTransparency

Manufacturers required to submit drug pricing and sales data under new reporting rules Drug manufacturers must report detailed pricing and sales data within specified timeframes.

Minnesota's new Senate Bill 2477 could revolutionize drug pricing transparency, but will it lead to lower costs or stifle innovation?

Click to read more!

#MN #CitizenPortal #HealthcareReform #DrugPricingTransparency #MinnesotaHealthcare #ConsumerEmpowerment

Senate passes SB789 regulating pharmacy benefits manager practices Senate enacts SB789 ensuring transparency and fair pricing from pharmacy benefits managers

Senate Bill 789 could revolutionize Oklahoma's pharmacy landscape by ensuring fair compensation for local pharmacies, but will it come at the cost of higher drug prices for consumers?

Read the full story

#OK #PharmacyReform #HealthcareAccess #CitizenPortal #DrugPricingTransparency